Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-06 Sale | 2024-11-08 4:10 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 51,110 | $26.36 | $1,347,050 | 109,150 (Direct) | View |
2024-10-14 Sale | 2024-10-16 4:44 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 51,110 | $26.27 | $1,342,752 | 160,260 (Direct) | View |
2024-10-01 Sale | 2024-10-02 5:52 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 385 | $23.48 | $9,040 | 104,209 (Direct) | View |
2024-10-01 Sale | 2024-10-02 5:51 pm | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 289 | $23.48 | $6,785 | 44,931 (Direct) | View |
2024-09-30 Sale | 2024-10-02 5:49 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $24.6 | $1,476,024 | 1,041,659 (Indirect Direct) | View |
2024-07-01 Sale | 2024-07-03 4:05 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 1,250 | $23.28 | $29,094 | 68,805 (Direct) | View |
2024-06-27 Sale | 2024-06-28 4:15 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $24.5 | $1,470,156 | 1,101,343 (Indirect Direct) | View |
2024-04-01 Sale | 2024-04-03 7:43 pm | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 23,687 | $31.02 | $734,805 | 70,060 (Direct) | View |
2024-04-01 Sale | 2024-04-03 7:40 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 3,401 | $32.12 | $109,240 | 104,594 (Direct) | View |
2024-04-01 Sale | 2024-04-03 7:39 pm | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 5,446 | $32.12 | $174,926 | 70,137 (Direct) | View |
2024-04-01 Sale | 2024-04-03 7:36 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 18,102 | $32.13 | $581,617 | 1,314,644 (Indirect Direct) | View |
2024-04-01 Sale | 2024-04-03 7:33 pm | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 4,534 | $32.12 | $145,632 | 209,913 (Direct) | View |
2024-03-28 Sale | 2024-04-01 4:10 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $33.86 | $2,031,402 | 1,179,445 (Indirect Direct) | View |
2024-02-13 Sale | 2024-02-15 2:34 pm | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 | 901,565 | $30.55 | $27,545,051 | 1,235,511 (Indirect) | View |
2024-01-31 Sale | 2024-02-02 4:05 pm | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 60,000 | $25.33 | $1,519,800 | 1,316,262 (Indirect Direct) | View |
2024-01-03 Sale | 2024-01-05 4:30 pm | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 1,907 | $26.42 | $50,383 | 80,495 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-17 Exercise | 2024-12-19 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 53,500 | $0.67 | 169,155 (Direct) | View |
2024-12-17 Exercise | 2024-12-19 4:10 pm | N/A 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 53,500 | $0 | 169,155 (Direct) | View |
2024-12-02 Option Award | 2024-12-04 07:22 am | N/A 2034-12-02 | Beam Therapeutics Inc. | BEAM | Guindo Chirfi Director | 39,086 | $0 | 39,086 (Direct) | View |
2024-10-14 Exercise | 2024-10-16 4:44 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 27,318 | $0.67 | 160,260 (Direct) | View |
2024-10-14 Exercise | 2024-10-16 4:44 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 1,457 | $7.22 | 160,260 (Direct) | View |
2024-10-14 Exercise | 2024-10-16 4:44 pm | 2024-04-03 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 41,754 | $0 | 160,260 (Direct) | View |
2024-10-14 Exercise | 2024-10-16 4:44 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 12,979 | $4.22 | 160,260 (Direct) | View |
2024-09-30 Option Award | 2024-10-02 5:51 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 2,500 | $0 | 44,931 (Direct) | View |
2024-08-31 Option Award | 2024-09-03 4:15 pm | N/A 2034-08-31 | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 5,000 | $0 | 5,000 (Direct) | View |
Ownership | 2024-08-19 4:15 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Cavanagh Bethany J SVP, Finance and Treasurer | 0 | $0 | 125,762 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:48 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | Shaw Christi Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:47 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:47 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | Ho Carole Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:45 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:42 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:42 pm | N/A 2034-06-05 | Beam Therapeutics Inc. | BEAM | Fishman Mark Director | 23,114 | $0 | 23,114 (Direct) | View |
2024-04-26 Option Award | 2024-04-29 4:10 pm | N/A 2034-04-26 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 37,500 | $0 | 107,637 (Direct) | View |
2024-04-03 Option Award | 2024-04-03 7:36 pm | 2024-04-03 2028-05-08 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 153,301 | $0 | 1,314,644 (Direct) | View |
2024-04-03 Option Award | 2024-04-03 7:33 pm | 2024-04-03 2028-05-08 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 40,297 | $0 | 209,913 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 27,500 | $0 | 75,583 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 27,500 | $0 | 93,747 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 35,000 | $0 | 174,150 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 27,500 | $0 | 107,995 (Direct) | View |
2024-03-31 Option Award | 2024-04-01 4:10 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 77,500 | $0 | 1,179,445 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer | 55,000 | $24.4 | 55,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer | 55,000 | $24.4 | 55,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer | 55,000 | $24.4 | 55,000 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Evans John M. CEO | 155,000 | $24.4 | 1,316,262 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-31 | Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President | 70,000 | $24.4 | 70,000 (Direct) | View |
2023-12-22 Other | 2023-12-27 10:56 am | N/A N/A | Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner | 29,549 | $0 | 4,938,538 (Indirect) | View |
2023-12-13 Option Award | 2023-12-14 4:15 pm | N/A 2033-12-13 | Beam Therapeutics Inc. | BEAM | Shaw Christi Director | 39,046 | $0 | 39,046 (Direct) | View |